This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Randomized Controlled Trial

. 2006 Jul;21(7):2030-1.

doi: 10.1093/ndt/gfl012. Epub 2006 Jan 31.

Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy

Peter Karl Jacobsen, Peter Rossing, Hans-Henrik Parving

PMID: 16449277
DOI: 10.1093/ndt/gfl012

Randomized Controlled Trial

Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy

Peter Karl Jacobsen et al. Nephrol Dial Transplant. 2006 Jul.

. 2006 Jul;21(7):2030-1.

doi: 10.1093/ndt/gfl012. Epub 2006 Jan 31.

Authors

Peter Karl Jacobsen, Peter Rossing, Hans-Henrik Parving

PMID: 16449277
DOI: 10.1093/ndt/gfl012

No abstract available

PubMed Disclaimer

Similar articles

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure.
Hollenberg NK. Hollenberg NK. Curr Hypertens Rep. 2001 Jun;3(3):178. Curr Hypertens Rep. 2001. PMID: 11421228 No abstract available.
Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S, Aurell M. Björck S, et al. J Am Soc Nephrol. 1990 Nov;1(5 Suppl 2):S59-63. J Am Soc Nephrol. 1990. PMID: 16989067 Review.
Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S. Andersen S. Dan Med Bull. 2004 Aug;51(3):274-94. Dan Med Bull. 2004. PMID: 16009059 Review. No abstract available.
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE. Kelly DJ, et al. Kidney Int. 2002 Jan;61(1):31-9. doi: 10.1046/j.1523-1755.2002.00088.x. Kidney Int. 2002. PMID: 11786082
[Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights].
Martinelli L, Ceriello A. Martinelli L, et al. Recenti Prog Med. 2003 Mar;94(3):131-5. Recenti Prog Med. 2003. PMID: 12677781 Review. Italian.

See all similar articles

Cited by

Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
Chang SY, Chen YW, Chenier I, Tran Sle M, Zhang SL. Chang SY, et al. Exp Diabetes Res. 2011;2011:521076. doi: 10.1155/2011/521076. Epub 2011 Oct 27. Exp Diabetes Res. 2011. PMID: 22110472 Free PMC article.
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF. Natale P, et al. Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD006257. doi: 10.1002/14651858.CD006257.pub2. Cochrane Database Syst Rev. 2024. PMID: 38682786 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information